Patents by Inventor Derrick Spencer KATAYAMA

Derrick Spencer KATAYAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240025979
    Abstract: The present invention relates to stable and low viscosity liquid pharmaceutical compositions comprising antibodies binding to human alpha synuclein and to methods for use of antibodies binding to human alpha synuclein for treating synucleinopathies or prodromal synucleinopathy, incl. suitable doses and/or dosing regimens. These antibodies for use in treatment of synucleinopathies or prodromal synucleinopathy may be formulated in the stable and low viscosity liquid pharmaceutical compositions of the invention.
    Type: Application
    Filed: June 26, 2023
    Publication date: January 25, 2024
    Inventors: Josefine NIELSEN SØDERBERG, Pekka Kallunki, Louise Buur, Frank Larsen, Henrik Rajesh Kumar Parshad, Anne Sofie Markussen, Mark Cornell Manning, Derrick Spencer Katayama, Magdalena Gauden, John Smith
  • Publication number: 20230372480
    Abstract: The present invention relates to anti-IL-36R formulations for administration to a subject.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 23, 2023
    Inventors: Sandra Nicole DENKINGER, Anna Maria STEINER, Derrick Spencer KATAYAMA, Rajni Prasad MEHRA, Ingo Michael PRESSER, Ravija SINGH, Sara Kay WRIGHT
  • Patent number: 11730812
    Abstract: The present invention relates to anti-interleukin-36 receptor (anti-IL-36R1) antibody formulations for administration to a subject.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: August 22, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Sandra Nicole Denkinger, Anna Maria Steiner, Derrick Spencer Katayama, Rajni Prasad Mehra, Ingo Michael Presser, Ravija Singh, Sara Kay Wright
  • Publication number: 20200282053
    Abstract: The present invention relates to anti-IL-36R formulations for administration to a subject.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 10, 2020
    Inventors: Sandra Nicole DENKINGER, Anna Maria STEINER, Derrick Spencer KATAYAMA, Rajni Prasad MEHRA, Ingo Michael PRESSER, Ravija SINGH, Sara Kay WRIGHT